MICHAEL INGRAM: Open Payments
NPI 1295767283 · BAY CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$36,483 in 68 payments from 11 companies in 2025. Trend: 2023 $17,684 · 2024 $44,578 · 2025 $36,483
Speaker / faculty: $23,460Consulting: $7,496Travel & lodging: $4,100Food & beverage: $1,426
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $20,778 |
| Janssen Pharmaceuticals, Inc | 19 | $14,086 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $1,132 |
| Neurocrine BioSciences, Inc. | 13 | $211 |
| Otsuka America Pharmaceutical, Inc. | 1 | $97 |
| Lundbeck LLC | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Sage Therapeutics, LLC | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Indivior Inc. | 1 | $18 |
Products named: CAPLYTA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, INGREZZA, REXULTI, TRINTELLIX, Auvelity, REJOYN.
Industry payments across MI — which companies pay providers there.
